Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Trial Comparing Rectal Indomethacin Alone Versus a Combination of Rectal Indomethacin and Oral Tacrolimus for Post-ERCP Pancreatitis Prophylaxis

NCT05252754 is registered in ClinicalTrials.gov with Johns Hopkins University as lead sponsor.

NCT NCT05252754
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05252754 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Trial Comparing Rectal Indomethacin Alone Versus a Combination of Rectal Indomethacin and Oral Tacrolimus for Post-ERCP Pancreatitis Prophylaxis
Lead sponsor
Johns Hopkins University
Phase
Phase 3
Overall status
Recruiting
Start date
January 18, 2023
Completion date
December 31, 2026
Enrollment
4,874 (estimated)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

post-ercp acute pancreatitis